CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K-Akt-mTOR pathway inhibition

por Liao, Yu-Xin, Lv, Ji-Yang, Zhou, Zi-Fei, Xu, Tian-Yang, Yang, Dong, Gao, Qiu-Ming, Fan, Lin, Li, Guo-Dong, Yu, Hai-Yang, Liu, Kai-Yuan
Publicado 2021